Share This

PR Newswire Asia's news > Health Care/Hospital

 |   Title only   |   Print    Next page > 
     
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024
SHANGHAI and NANJING , China and SAN JOSE, Calif. , June 15, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing ...
2024-06-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024
SHANGHAI , June 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies ...
2024-06-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. Ascentage Pharma to receive an option payment of ...
2024-06-14T    Banking/Financial Service   Biotechnology   Computer/Electronics   Health Care/Hospital 
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
HANGZHOU, China , June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China , announced today ...
2024-06-14T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
SAN FRANCISCO and SUZHOU, China , June 14, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
2024-06-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
TraceLink MINT Awarded 2024 Supply Chain Visibility Solution of the Year by SupplyTech Breakthrough
TraceLink Recognized with Top Honor in Supply Chain Visibility at SupplyTech Breakthrough Awards ...
2024-06-14T    Computer Software   Computer/Electronics   Health Care/Hospital   Transportation 
Give Dad a Radiant Smile: Keosaa Electric Toothbrushes Discounted This Father's Day
NEW YORK , June 14, 2024 /PRNewswire/ -- Father's Day is just around the corner, and what better way to show appreciation for the fathers in your life than by gifting them superior oral care? Keosaa ...
2024-06-14T    Health Care/Hospital   Household/Consumer/Cosmetics 
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
SAINT-CLOUD, France , June 13, 2024 /PRNewswire/ -- Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals ...
2024-06-13T    Health Care/Hospital   Medical/Pharmaceuticals 
EVERISE NAMED A TOP FIVE MOST INSPIRING WORKPLACE IN LATIN AMERICA
PLANTATION, Fla. , June 13, 2024 /PRNewswire/ -- Everise, a leader in transforming customer service for global healthcare companies, today announced being named a top five 2024 Inspiring Workplace ...
2024-06-13T    Health Care/Hospital   Workforce Management/Human Resources 
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
TORONTO , June 13, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science ...
2024-06-13T    Banking/Financial Service   Biotechnology   Education   Health Care/Hospital 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.